NKF #SCM14 Meeting Coverage

Check out our ongoing coverage of the meeting in Las Vegas.

Practice Management: How to Buy Technology

Out-of-pocket is one option, but it may make better business sense to lease equipment or borrow money to pay for it.

Spotlight on Hypogonadism: May Raise CKD Death Risk

Second lowest quintile of T levels had a 53% increased death risk.

Expert Q&A: Renal Stenting and the CORAL Study

CORAL study chair Lance Dworkin, MD, discusses his controversial findings with us.

Ongoing Clinical Trials

Our website has the latest ongoing clinical trials in nephrology and urology.

NKF 2014 Coverage



Follow our live coverage of the NKF's 2014 Spring Clinical Meetings in Las Vegas.


Coverage by Topic:

Anemia
| Hyperphosphatemia | General News

Complete Coverage


Limiting Phosphorus Additives Aids Phosphatemia Control

Limiting Phosphorus Additives Aids Phosphatemia Control

Researchers observed reduced phosphorus levels in HD patients whose diet restricted intake of phosphorus additives.

Phosphate Binder May Eliminate Need for IV Iron

Phosphate Binder May Eliminate Need for IV Iron

Iron absorbed from oral ferric citrate boosted iron stores and sustained hemoglobin levels.

An Inflammatory Case of Acute Kidney Injury

An Inflammatory Case of Acute Kidney Injury

A 70-year-old woman presented with acute kidney injury. She has a 10-year history of type 2 diabetes and ...

Long-Term Renal Function Following Urinary Diversion

Long-Term Renal Function Following Urinary Diversion

A 54-year-old man with muscle-invasive bladder cancer underwent cystoprostatectomy and ileal orthotopic neobladder urinary diversion.

Pathology demonstrated pT2N0M0 Stage II disease. ...

A Case of Hematuria and Flank Pain

A Case of Hematuria and Flank Pain

A 20-year-old white man presented to the emergency room with severe, left-sided, upper abdominal pain that began upon awakening two ...

Adrenal Mass in a Patient with High-Risk RCC

Adrenal Mass in a Patient with High-Risk RCC

A 63-year-old man with history of a pT2N0M0 Stage II Grade 3 clear cell renal cell carcinoma who had undergone ...

ADEMPAS (riociguat)

For hypertension.

FARXIGA™ (dapagliflozin)

For type 2 diabetes mellitus.

OPSUMIT® (macitentan)

For hypertension.

MYRBETRIQ™ (mirabegron)

For overactive bladder.

Cartoons

Online Poll


April Issue Preview


View more digital issues here.
Read articles from the issue here.

Sign Up for Free e-newsletters